A $153 billion spending bill that cleared a House subcommittee June 17 seeks to abolish the Agency for Healthcare Research and Quality, the federal entity that funds patient-centered outcomes research and monitors the manner in which medicine is practiced in the U.S.
FDA has initiated the approval of leucovorin calcium tablets, rushing them to market as part of a push from the Trump administration to identify potential treatments for autism spectrum disorder.
